Panama Petrochem posted 61% higher PAT of Rs.71.08 cr. in Q4FY26 and FY26 PAT of Rs.212.50 cr., while declaring a 150% dividend. Debt-free with reserves of Rs.1,456.58 cr. against equity of Rs.12 cr., a P/E of 11 and ROCE of 20.4%, the stock looks attractive at Rs.329 versus its all-time high of Rs.452.

As per market grapevine, stocks to watch include 20 Microns, AVT Natural, Chemcon, FDC, GPPL, IOLCP, Jamna Auto, Jenburkt Pharma, Jumbo Bag, Metroglobal, Rajesh Power, KLL, Panama Petrochem, POEL, Mazda, Rupa, Univastu, Va Tech Wabag, Vodafone Idea, Wanbury and Yes Bank.

Enam’s investment journey demonstrates the power of long-term compounding. Its portfolio grew from Rs.1,853 cr. across 29 stocks in 2016 to Rs.15,720 cr. across 31 stocks in 2026, delivering an 8.5x growth over a decade

As per astrological views, key turning dates are 1st, 3rd, 5th, 8th, 10th and 12th June 2026. The period from 1st to 23rd June 2026 may remain challenging, with the possibility of heightened conflicts and volatility. Caution is advised in both markets and personal matters during this phase.

Jayaswal Neco Industries posted a strong FY26 turnaround with PAT surging 311% to Rs.463.11 cr. and revenue rising 18.87%. Expansion projects including a Rs.720 cr. pellet plant and solar partnership with Waaree strengthen long-term growth visibility. The company also approved preferential warrants worth around Rs.200 cr. to promoter-linked Vibrant Enterprises.

Invicta Diagnostic reported FY26 consolidated total income of Rs.33.04 cr., EBITDA of Rs.10.45 cr. with margin of 31.63%, and NP of Rs.4.87 cr. with margin of 14.74%. It has also expanded its Tele-Radiology services internationally with commencement of diagnostic reporting for clients in the USA.

Sukhjit Starch & Chemicals board will meet on 27-5-2026 for FY26 results and dividend. As per market grapevine, strong Q4 results may help stock cross its 52-week high of Rs.228.

Atlanta Electricals notched 70% higher FY26 PAT of Rs.202 cr. EBITDA margin expanded 300 bps to 18.6% and the company became debt-free after repaying Rs.340 cr. debt. Very optimistic FY27 outlook. Stock may deliver strong returns.

IOL Chemicals and Pharmaceuticals reported 158% QoQ jump in Q4FY26 PAT to Rs.53.16 cr. while FY26 PAT rose to Rs.137.64 cr. The company incurred Rs.164 cr. capex towards expansion and automation. Stock may surpass its all-time high of Rs.178.

Short-term negative for emerging markets like India: The new Fed Chair (Kevin Warsh) wants to shrink the Fed’s balance sheet rather than expand it, meaning no more QE printing and no more easy money.